Director/PDMR Shareholding

Rhea-AI Summary

Amryt Pharma plc announced a transaction by its Chairman, Ray Stafford, under the EU Market Abuse Regulation. On March 12, 2021, Stafford purchased 300,100 ordinary shares at a price of £2.00 per share, totaling £600,200. This transaction took place on the London Stock Exchange, AIM.

Positive

• Ray Stafford's purchase of 300,100 shares demonstrates his confidence in the company's future.

Negative

• None.

Amryt Pharma plc

Director/PDMR Shareholding

The following notification is made in accordance with the requirements of the EU Market Abuse Regulation (as it forms part of UK law pursuant to the European Union (Withdrawal) Act 2018).

Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them

1
Details of the person discharging managerial responsibilities/person closely associated

a)
Name

Ray Stafford

2
Reason for the notification

a)
Position/status

Chairman

b)
Initial Notification Amendment

Initial Notification

  
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Amryt Pharma plc

b)
LEI
213800YNUJEOJ8L4T95

4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial  instrument, 
type  of
instrument
Identification code
Ordinary shares of £0.06 each

GB00BKLTQ412
b)
Nature of the transaction   

Purchase of Shares

c)
Price(s) and volume(s)

Price(s)	Volume(s)
£2.00	300,100 ordinary shares

d)
Aggregated information
— Aggregated volume
— Price

N/A – single transaction

e)
Date of the transaction

March 12, 2021

f)
Place of the transaction

London Stock Exchange, AIM

Contacts Joe Wiley, CEO / Rory Nealon, CFO/COO, +353 (1) 518 0200, ir@amrytpharma.com Edward Mansfield, Shore Capital, NOMAD, +44 (0) 207 468 7906, edward.mansfield@shorecap.co.uk Tim McCarthy, LifeSci Advisors, LLC, +1 (212) 915 2564, tim@lifesciadvisors.com Amber Fennell, Consilium Strategic Communications, +44 (0) 203 709 5700, fennell@consilium-comms.com

FAQ

What transaction did Ray Stafford of Amryt Pharma conduct on March 12, 2021?

On March 12, 2021, Ray Stafford purchased 300,100 ordinary shares at £2.00 each.

How many shares did the Chairman of Amryt Pharma buy?

Ray Stafford bought 300,100 ordinary shares.

What was the price per share for the transaction by Ray Stafford?

The price per share was £2.00.

Where did Ray Stafford's share transaction take place?

The transaction took place on the London Stock Exchange, AIM.